Tag: HIVA
One Dose of Benzathine Penicillin G Noninferior to Three Doses for Syphilis
One dose was noninferior to three doses for serologic response at six months among patients with early syphilis
HIV Infections Projected to Rise With Cessation of Ryan White Services
Ending Ryan White services in July 2025 could result in 75,436 additional infections through 2030
One Dose of Benzathine Penicillin G Noninferior to Three Doses for Syphilis
One dose was noninferior to three doses for serologic response at six months among patients with early syphilis
More Than Half of Infants Diagnosed With HIV Did Not Receive Postnatal HIV Prophylaxis
Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black
U.S. Cuts to HIV Aid Could Lead to 4 Million Deaths, U.N. Warns
NRTI Use Linked to Risk for Primary Open-Angle Glaucoma
Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
Approval marks first and only twice-yearly option available in the United States for PrEP
Anal Cancer Screening Cost-Effective for HIV+ Men Who Have Sex With Men ≥35 Years...
Screening initiation at age 35 years or older using cytology dominated initiation at ages 40 and 45 years or older
Long-Lasting HIV Prevention Shot Headed Toward Approval
Initiation of HIV PrEP in Young Adults Rose in Recent Years
PrEP dispensing and initiation have increased but PrEP persistence has decreased
